Effect of caffeine on the plasma protein binding and the disposition of ceftriaxone.
The effects of caffeine on the in-vitro protein binding and the pharmacokinetics of ceftriaxone (a highly protein bound cephalosporin) were investigated. Caffeine failed to decrease in-vitro protein binding of ceftriaxone. Rabbit plasma concentrations of ceftriaxone (30 mg kg-1 i.v.) were elevated significantly (P less than 0.05 at 0.3, 0.6 and 1 h after injection) when caffeine 5 or 10 mg kg-1 i.v. was co-administered compared with ceftriaxone given alone. Caffeine increased the volume of distribution of the central compartment (V1) for ceftriaxone significantly from 49 +/- 38 ml kg-1 (mean +/- s.d., n = 6) to 97 +/- 33 ml kg-1 (caffeine 5 mg kg-1, P less than 0.05), and 94 +/- 8 ml kg-1 (caffeine 10 mg kg-1, P less than 0.05) and decreased the volume of distribution of the peripheral compartment (V2) from 145 +/- 106 ml kg-1 (mean +/- s.d., n = 6) to 31 +/- 18 ml kg-1 (caffeine 5 mg kg-1, P less than 0.5) and 36 +/- 31 ml kg-1 (caffeine 10 mg kg-1, P less than 0.1). The rate of transfer of ceftriaxone to the peripheral compartment (k12) was also decreased significantly (P less than 0.05) after caffeine. The elevated plasma concentration of ceftriaxone, increased V1 value and the decreased V2 and k12 values are probably the result of caffeine altering the distribution of ceftriaxone to the central and the peripheral compartments.
Kwon
K I
KI
Bourne
D W
DW
Ho
P C
PC
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism*; D002110:Caffeine / Q000494:pharmacology*; D002443:Ceftriaxone / Q000097:blood / Q000378:metabolism* / Q000652:urine; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D011485:Protein Binding / Q000187:drug effects; D011817:Rabbits; D014018:Tissue Distribution
D001798:Blood Proteins; D002110:Caffeine; D002443:Ceftriaxone